Meta-analysis of the safety of Yangzhengxiaoji capsule for the treatment of cancer and precancerosis

Chinese Journal of Clinical Oncology

Volumn 40, Issue 21, 2013, Pages 1318-1323

  Xue, Kan ^a   Shan, Fei ^a   Ji, Jiafu ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Cancer; Meta analysis; Precancerosis; Safety; Yangzhengxiaoji capsule

Indexed keywords

ANTINEOPLASTIC AGENT; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG; YANGZHENGXIAOJI CAPSULE;

ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARDIOTOXICITY; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CHINESE; CLINICAL TRIAL (TOPIC); COCHRANE LIBRARY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HUMAN; LEUKOCYTE; MALIGNANT NEOPLASTIC DISEASE; MEDLINE; META ANALYSIS; NEPHROTOXICITY; NEUROTOXICITY; PRECANCER; SYSTEMATIC REVIEW; THROMBOCYTE; TOXIC HEPATITIS;

EID: 84891596228     PISSN: 10008179     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1000-8179.20131476     Document Type: Article

References (22)

1. http://www.moh.gov.cn/htmlfiles/zwgkzt/ptjnj/year2011/index2011.html
2. http://www.cnki.net/kcms/detail/11.5529.R.20130826.1329.009.html